SCHEMBL6851706

SCHEMBL6851706

Cc1cc(C)c(S(=O)(=O)OC(C)NC(=O)OC(C)(C)C)c(C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
LCK P06239 3/20 0.39
LMNA P02545 5/20 0.39
KMT2A Q03164 4/20 0.39
MEN1 O00255 2/20 0.39
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTT P42858 4/20 0.38
NPSR1 Q6W5P4 4/20 0.38
TP53 P04637 3/20 0.38
XBP1 P17861 3/20 0.38
MAPK1 P28482 3/20 0.38
HSD17B10 Q99714 3/20 0.38
PKM P14618 3/20 0.38
HSP90AA1 P07900 1/20 0.38
GAA P10253 1/20 0.38
ATM Q13315 2/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2288800 0.80 CA2 (0.44) LMNAKMT2AMEN1MAPTHTT
SCHEMBL25047 0.77 NFKB1 (0.42) NFKB1NFKB2RELALCKLMNA
SCHEMBL1618029 0.75 CA1 (0.46) NFKB1NFKB2RELALCKLMNA
SCHEMBL4289710 0.74 CA1 (0.51) NFKB1NFKB2RELALCKMAPT
SCHEMBL2341219 0.73 CA1 (0.46) KMT2AHSD17B10CA1CA2CA7
SCHEMBL28525080 0.72 MAPT (0.44) NFKB1NFKB2RELALCKLMNA
SCHEMBL31135406 0.72 NFKB1 (0.41) NFKB1NFKB2RELALCKLMNA
SCHEMBL23846018 0.70 NFKB1 (0.41) NFKB1NFKB2RELALCKLMNA
SCHEMBL14778116 0.70 CA1 (0.44) LMNAKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL13134138 0.70 CA1 (0.44) LMNAKMT2AMEN1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1389211-A1 3,7-DIAZYBICYCLO 3.3.1] FORMULATIONS AS ANTIARRHYTMIC COMPOUNDS AstraZeneca AB (SE) 2004-02-18 EP disclosed
WO-2002083687-A1 3,7-DIAZYBICYCLO [3.3.1] FORMULATIONS AS ANTIARRHYTMIC COMPOUNDS ASTRAZENECA AB (SE) 2002-10-24 WO disclosed